What is the current valuation of the US drug allergy market?

The market valuation was $3750.0 Million in 2024. Read More

What is the projected market size for the US drug allergy market by 2035?

The projected valuation for 2035 is $10406.16 Million. Read More

What is the expected CAGR for the US drug allergy market during the forecast period 2025 - 2035?

The expected CAGR is 9.72% during the forecast period. Read More

Which companies are the key players in the US drug allergy market?

Key players include Allergan, Sanofi, Bristol-Myers Squibb, Merck & Co., GlaxoSmithKline, AstraZeneca, Novartis, Pfizer, and Johnson & Johnson. Read More

What are the main segments of the US drug allergy market?

The main segments include Type, Treatment, Diagnosis, and End-Users. Read More

What was the valuation of the nonimmunologic segment in 2024?

The nonimmunologic segment was valued at $1500.0 Million in 2024. Read More

How much is the antihistamines treatment segment projected to be worth by 2035?

The antihistamines treatment segment is projected to reach $3000.0 Million by 2035. Read More

What is the valuation range for skin tests in the US drug allergy market?

The valuation range for skin tests is between $1000.0 Million and $2500.0 Million. Read More

Which end-user segment had the highest valuation in 2024?

The hospitals & clinics segment had the highest valuation at $1875.0 Million in 2024. Read More

What is the projected growth for the treatment of anaphylaxis segment by 2035?

The treatment of anaphylaxis segment is projected to grow to $2500.0 Million by 2035. Read More

US Drug Allergy Market

ID: MRFR/Pharma/17478-HCR

100 Pages

Satyendra Maurya

Last Updated: April 06, 2026

US Drug Allergy Market Research Report By Type (nonimmunologic, immunologic, others), By Treatment (corticosteroids, withdrawal of the drug, antihistamines, treatment of anaphylaxis, others), By Diagnosis (blood tests, skin tests, patch test, others) and By End Users (academic institutes, medical research centers, hospitals & clinics, others) - Growth & Industry Forecast 2025 To 2035

Summary Table of Contents Segmentation Download PDF

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1.1 EXECUTIVE SUMMARY
1.1.1 Market Overview
1.1.2 Key Findings
1.1.3 Market Segmentation
1.1.4 Competitive Landscape
1.1.5 Challenges and Opportunities
1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
2.1 MARKET INTRODUCTION
2.1.1 Definition
2.1.2 Scope of the study
2.1.2.1 Research Objective
2.1.2.2 Assumption
2.1.2.3 Limitations
2.2 RESEARCH METHODOLOGY
2.2.1 Overview
2.2.2 Data Mining
2.2.3 Secondary Research
2.2.4 Primary Research
2.2.4.1 Primary Interviews and Information Gathering Process
2.2.4.2 Breakdown of Primary Respondents
2.2.5 Forecasting Model
2.2.6 Market Size Estimation
2.2.6.1 Bottom-Up Approach
2.2.6.2 Top-Down Approach
2.2.7 Data Triangulation
2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
3.1 MARKET DYNAMICS
3.1.1 Overview
3.1.2 Drivers
3.1.3 Restraints
3.1.4 Opportunities
3.2 MARKET FACTOR ANALYSIS
3.2.1 Value chain Analysis
3.2.2 Porter's Five Forces Analysis
3.2.2.1 Bargaining Power of Suppliers
3.2.2.2 Bargaining Power of Buyers
3.2.2.3 Threat of New Entrants
3.2.2.4 Threat of Substitutes
3.2.2.5 Intensity of Rivalry
3.2.3 COVID-19 Impact Analysis
3.2.3.1 Market Impact Analysis
3.2.3.2 Regional Impact
3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
4.1 Food, Beverages & Nutrition, BY Type (USD Million)
4.1.1 nonimmunologic
4.1.2 immunologic
4.1.3 others
4.2 Food, Beverages & Nutrition, BY Treatment (USD Million)
4.2.1 corticosteroids
4.2.2 withdrawal of the drug
4.2.3 antihistamines
4.2.4 treatment of anaphylaxis
4.2.5 others
4.3 Food, Beverages & Nutrition, BY Diagnosis (USD Million)
4.3.1 blood tests
4.3.2 skin tests
4.3.3 patch tests
4.3.4 others
4.4 Food, Beverages & Nutrition, BY End-Users (USD Million)
4.4.1 academic institutes
4.4.2 medical research centers
4.4.3 hospitals & clinics
4.4.4 others
5 SECTION V: COMPETITIVE ANALYSIS
5.1 Competitive Landscape
5.1.1 Overview
5.1.2 Competitive Analysis
5.1.3 Market share Analysis
5.1.4 Major Growth Strategy in the Food, Beverages & Nutrition
5.1.5 Competitive Benchmarking
5.1.6 Leading Players in Terms of Number of Developments in the Food, Beverages & Nutrition
5.1.7 Key developments and growth strategies
5.1.7.1 New Product Launch/Service Deployment
5.1.7.2 Merger & Acquisitions
5.1.7.3 Joint Ventures
5.1.8 Major Players Financial Matrix
5.1.8.1 Sales and Operating Income
5.1.8.2 Major Players R&D Expenditure. 2023
5.2 Company Profiles
5.2.1 Allergan (IE)
5.2.1.1 Financial Overview
5.2.1.2 Products Offered
5.2.1.3 Key Developments
5.2.1.4 SWOT Analysis
5.2.1.5 Key Strategies
5.2.2 Sanofi (FR)
5.2.2.1 Financial Overview
5.2.2.2 Products Offered
5.2.2.3 Key Developments
5.2.2.4 SWOT Analysis
5.2.2.5 Key Strategies
5.2.3 Bristol-Myers Squibb (US)
5.2.3.1 Financial Overview
5.2.3.2 Products Offered
5.2.3.3 Key Developments
5.2.3.4 SWOT Analysis
5.2.3.5 Key Strategies
5.2.4 Merck & Co. (US)
5.2.4.1 Financial Overview
5.2.4.2 Products Offered
5.2.4.3 Key Developments
5.2.4.4 SWOT Analysis
5.2.4.5 Key Strategies
5.2.5 GlaxoSmithKline (GB)
5.2.5.1 Financial Overview
5.2.5.2 Products Offered
5.2.5.3 Key Developments
5.2.5.4 SWOT Analysis
5.2.5.5 Key Strategies
5.2.6 AstraZeneca (GB)
5.2.6.1 Financial Overview
5.2.6.2 Products Offered
5.2.6.3 Key Developments
5.2.6.4 SWOT Analysis
5.2.6.5 Key Strategies
5.2.7 Novartis (CH)
5.2.7.1 Financial Overview
5.2.7.2 Products Offered
5.2.7.3 Key Developments
5.2.7.4 SWOT Analysis
5.2.7.5 Key Strategies
5.2.8 Pfizer (US)
5.2.8.1 Financial Overview
5.2.8.2 Products Offered
5.2.8.3 Key Developments
5.2.8.4 SWOT Analysis
5.2.8.5 Key Strategies
5.2.9 Johnson & Johnson (US)
5.2.9.1 Financial Overview
5.2.9.2 Products Offered
5.2.9.3 Key Developments
5.2.9.4 SWOT Analysis
5.2.9.5 Key Strategies
5.3 Appendix
5.3.1 References
5.3.2 Related Reports
6 LIST OF FIGURES
6.1 MARKET SYNOPSIS
6.2 US MARKET ANALYSIS BY TYPE
6.3 US MARKET ANALYSIS BY TREATMENT
6.4 US MARKET ANALYSIS BY DIAGNOSIS
6.5 US MARKET ANALYSIS BY END-USERS
6.6 KEY BUYING CRITERIA OF FOOD, BEVERAGES & NUTRITION
6.7 RESEARCH PROCESS OF MRFR
6.8 DRO ANALYSIS OF FOOD, BEVERAGES & NUTRITION
6.9 DRIVERS IMPACT ANALYSIS: FOOD, BEVERAGES & NUTRITION
6.10 RESTRAINTS IMPACT ANALYSIS: FOOD, BEVERAGES & NUTRITION
6.11 SUPPLY / VALUE CHAIN: FOOD, BEVERAGES & NUTRITION
6.12 FOOD, BEVERAGES & NUTRITION, BY TYPE, 2024 (% SHARE)
6.13 FOOD, BEVERAGES & NUTRITION, BY TYPE, 2024 TO 2035 (USD Million)
6.14 FOOD, BEVERAGES & NUTRITION, BY TREATMENT, 2024 (% SHARE)
6.15 FOOD, BEVERAGES & NUTRITION, BY TREATMENT, 2024 TO 2035 (USD Million)
6.16 FOOD, BEVERAGES & NUTRITION, BY DIAGNOSIS, 2024 (% SHARE)
6.17 FOOD, BEVERAGES & NUTRITION, BY DIAGNOSIS, 2024 TO 2035 (USD Million)
6.18 FOOD, BEVERAGES & NUTRITION, BY END-USERS, 2024 (% SHARE)
6.19 FOOD, BEVERAGES & NUTRITION, BY END-USERS, 2024 TO 2035 (USD Million)
6.20 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
7.1 LIST OF ASSUMPTIONS
7.1.1
7.2 US MARKET SIZE ESTIMATES; FORECAST
7.2.1 BY TYPE, 2025-2035 (USD Million)
7.2.2 BY TREATMENT, 2025-2035 (USD Million)
7.2.3 BY DIAGNOSIS, 2025-2035 (USD Million)
7.2.4 BY END-USERS, 2025-2035 (USD Million)
7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

US Food, Beverages & Nutrition Market Segmentation

Food, Beverages & Nutrition By Type (USD Million, 2025-2035)

nonimmunologic
immunologic
others

Food, Beverages & Nutrition By Treatment (USD Million, 2025-2035)

corticosteroids
withdrawal of the drug
antihistamines
treatment of anaphylaxis
others

Food, Beverages & Nutrition By Diagnosis (USD Million, 2025-2035)

blood tests
skin tests
patch tests
others

Food, Beverages & Nutrition By End-Users (USD Million, 2025-2035)

academic institutes
medical research centers
hospitals & clinics
others

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Features	License Type
Features	Single User	Multiuser License	Enterprise User
Price	$4,950	$5,950	$7,250
Maximum User Access Limit	1 User	Upto 10 Users	Unrestricted Access Throughout the Organization
Free Customization	✓	✓	✓
Direct Access to Analyst	✓	✓	✓
Deliverable Format	✓	✓	✓
Platform Access	✗	✗	✓
Discount on Next Purchase	10%	15%	15%
Printable Versions	✗	✗	✓